0001628280-26-027019
SEC filingNet income declined 9.0% to $2.6B year-over-year, while free cash flow remained negative at -$752M. The results reflect a strategic pivot toward smoke-free products, with strong volume growth in the heat-not-burn category offset by working capital timing and derivative collateral pressures.
Cash flow generation faced headwinds during the quarter, with free cash flow settling at -$752M. This result stemmed from net cash used in operating activities of $399M against capital expenditures of $353M. The operating cash outflow was primarily attributed to changes in the cash collateral posted for derivative instruments, a dynamic directly linked to the depreciation of the Euro and Swiss franc against the U.S. dollar. Additionally, management noted that working capital timing, including excise tax payments, contributed to the cash usage. Capital expenditures decreased year-over-year from $404M to $353M, reflecting a disciplined approach to capital deployment.
To manage ongoing liquidity requirements amidst these cash flow dynamics, the company continues to utilize a commercial paper program as part of its broader cash management strategy. This approach is supported by long-term and short-term debt financing capabilities. Management highlighted that marketing, administration, and research costs, including restructuring charges, are not allocated to segments, focusing segment profitability measures on core operational performance. Looking forward, the company faces a predictable regulatory environment regarding excise taxes, with harmonized HTP and cigarette tax increases scheduled to begin in April 2027, providing visibility through 2029.